在大流行病期间诊断出的癌症患者由于护理延迟,存活率低于一年,估计造成17 400人超额死亡。 Cancer patients diagnosed during the pandemic had lower one-year survival rates due to delayed care, causing an estimated 17,400 excess deaths.

JAMA肿瘤学的一项新研究发现,2020年和2021年诊断出的癌症患者,尽管总体癌症死亡率持续下降,但从2015年到2019年,在多种癌症类型和阶段中,其一年存活率低于被诊断出的癌症患者的一年存活率。 A new study in JAMA Oncology finds that cancer patients diagnosed in 2020 and 2021 had lower one-year survival rates than those diagnosed from 2015 to 2019, across multiple cancer types and stages, despite ongoing declines in overall cancer death rates. 研究人员分析了100多万个病例,估计在诊断一年内约有17 400人超额死亡,这很可能是由于与大流行病有关的筛查、诊断和治疗延误造成的。 Researchers analyzed over 1 million cases and estimate about 17,400 excess deaths within a year of diagnosis, likely due to pandemic-related delays in screening, diagnosis, and treatment. 虽然确切原因仍不清楚,但专家说,医疗保健系统中断是一个关键因素。 While the exact causes remain unclear, experts say healthcare system disruptions were a key factor.